NASDAQ: PMN - ProMIS Neurosciences, Inc.

半年間の収益性: -47.74%
セクタ: Healthcare

プロモーションスケジュール ProMIS Neurosciences, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils.

さらに詳しく
The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

ISIN CA74346M4065
Цена ао 1.94
Выручка 0
EBITDA -0.0044
Число акций ао 0.01229 млрд
P/S 56837.14
P/BV 171.6
EV/EBITDA -9.02
Сайт https://www.promisneurosciences.com
Валюта usd
IPO date 2007-07-17
Sector Health Care
Industry Biotechnology
Валюта отчета usd
1日あたりの価格変動: -0.0392% (1.0194)
週ごとの価格変動: -1.07% (1.03)
月ごとの料金変更: -17.15% (1.23)
3ヶ月間の価格変動: -51.29% (2.092)
半年間の価格変動: -47.74% (1.95)
年間の価格変動: -44.32% (1.83)
3年間の価格推移: +579.33% (0.15)
5年間の価格推移: +466.11% (0.18)
年初からの価格変動: -27.21% (1.4)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 0 0
P/BV 2.24 7
P/E 0 0
EV/EBITDA 0.2826 10
合計: 4.63

効率

名前 意味 学年
ROA, % -73.22 0
ROE, % -265.68 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA 0 10
合計: 9.6

成長の衝動

名前 意味 学年
収益性 Revenue, % 0 0
収益性 Ebitda, % 150.22 10
収益性 EPS, % -17.95 0
合計: 6
さらに詳しく

機関 音量 共有, %
Sphera Funds Management Ltd. 1834042 9.67
Ally Bridge Group (NY) LLC 1066674 5.63
Affinity Asset Advisors, LLC 265958 1.4
Northeast Financial Consultants Inc 100000 0.53
IEQ CAPITAL, LLC 30799 0.16
Fiduciary Trust Company (MA) 20008 0.11
Kingsview Wealth Management, LLC 11100 0.06
Claret Asset Management Corp 10830 0.06
UBS Group AG 5926 0.03
Bank of America Corporation 1666 0.01



スーパーバイザー 役職 支払い 生年
Dr. Neil R. Cashman M.D. Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director 333.8k 1952 (72 年)
Mr. Gavin T. Malenfant Chief Operating Officer 413.49k 1964 (60 年)
Mr. Daniel E. Geffken M.B.A. Chief Financial Officer 89.99k 1957 (67 年)
Dr. Johanne Kaplan Ph.D. Chief Development Officer 263.07k 1960 (64 年)
Dr. Ernest D. Bush Ph.D. Head of Pharmacology/Toxicology & Senior Consultant N/A
Dr. David Wishart Ph.D. Chief Physics Officer N/A
Mr. Dennis Chen Ph.D. Head of Manufacturing & Senior Consultant N/A
Dr. Larry Douglas Altstiel M.D., Ph.D. Chief Medical Officer N/A 1950 (74 年)
Mr. Neil K. Warma M.B.A. President, Interim CEO & Director 40k 1963 (61 年)
Mr. Eugene W. Williams Co-Founder & Chairman 1959 (65 年)

住所: Canada, Toronto. ON MS E, 1920 Yonge Street - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.promisneurosciences.com